ROVATI, LUCIO CLAUDIO,D'AMATO, MASSIMO MARIA,MENGS, ULRICH,POHL, RALF-TORSTEN,FERENCI, PETER,ROVATI LUCIO CLAUDIO,DAMATO MASSIMO MARIA,MENGS ULRICH,POHL RALF-TORSTEN,FERENCI PETER
申请号：
PL08849759
公开号：
PL2219642T3
申请日:
2008.11.14
申请国别(地区):
PL
年份:
2012
代理人:
摘要：
The invention relates to a silibinin component for use in the treatment of hepatitis C in a patient who does not respond to ribavirin/interferon therapy.
